GRO Biosciences
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
GRO Biosciences transforms protein therapeutics with new amino acid building blocks to treat incurable diseases.
Insights
Recent Funding GRO Biosciences secured $60.3M in Series B financing, indicating financial stability and potential for investment in their innovative protein therapeutics.
Key Personnel Hiring The appointment of experienced industry professionals like Tracey Lodie, Nicole Paulk, and Rakhshita Dhar to executive positions and advisory boards enhances GRO Biosciences' credibility and network within the pharmaceutical sector.
Advanced Technology Stack Utilizing technologies like Python, Cloudflare, and WordPress, GRO Biosciences demonstrates a commitment to innovation and efficiency in their operations, appealing to tech-savvy clients.
Niche Market Positioning Specializing in transforming protein therapeutics with new amino acid building blocks, GRO Biosciences distinguishes itself in a niche market, offering unique solutions and sales opportunities to address incurable diseases.
Competitive Landscape Analysis By benchmarking against similar companies like Notch Therapeutics, Lygos, and Insilico Medicine, GRO Biosciences can identify potential clients, strategic partnerships, and market trends for targeted sales and growth opportunities.
Similar companies to GRO Biosciences
GRO Biosciences Tech Stack
GRO Biosciences uses 8 technology products and services including WordPress, Cloudflare, Microsoft Word, and more. Explore GRO Biosciences's tech stack below.
- WordPressContent Management System
- CloudflareContent Management System
- Microsoft WordEditors
- Font AwesomeFont Scripts
- wpBakeryPage Builders
- PythonProgramming Languages
- Contact Form 7Web Platform Extensions
- MailChimp for WordPressWeb Platform Extensions
Media & News
GRO Biosciences's Email Address Formats
GRO Biosciences uses at least 1 format(s):
| GRO Biosciences Email Formats | Percentage |
| First.Last@grobio.com | 88% |
| FLast@grobio.com | 6% |
| Fir.Last@grobio.com | 3% |
| FirstLast@grobio.com | 3% |
Frequently Asked Questions
Where is GRO Biosciences's headquarters located?
GRO Biosciences's main headquarters is located at Pagliuca Harvard Life Lab 127 Western Ave. Boston, MA 02134 US. The company has employees across 2 continents, including North AmericaAsia. What is GRO Biosciences's official website and social media links?
GRO Biosciences's official website is grobio.com and has social profiles on LinkedIn.How much revenue does GRO Biosciences generate?
As of August 2024, GRO Biosciences's annual revenue reached $3.8M. What is GRO Biosciences's NAICS code?
GRO Biosciences's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.How many employees does GRO Biosciences have currently?
As of August 2024, GRO Biosciences has approximately 34 employees across 2 continents, including North AmericaAsia. Key team members include Chief Scientific Officer: C. J. G.Chief Business Officer: E. S.Chief Development Officer: T. L.. Explore GRO Biosciences's employee directory with LeadIQ.What industry does GRO Biosciences belong to?
GRO Biosciences operates in the Pharmaceutical Manufacturing industry. What technology does GRO Biosciences use?
GRO Biosciences's tech stack includes WordPressCloudflareMicrosoft WordFont AwesomewpBakeryPythonContact Form 7MailChimp for WordPress. What is GRO Biosciences's email format?
GRO Biosciences's email format typically follows the pattern of . Find more GRO Biosciences email formats with LeadIQ. How much funding has GRO Biosciences raised to date?
As of August 2024, GRO Biosciences has raised $60M in funding. The last funding round occurred on Jul 19, 2024 for $60M.When was GRO Biosciences founded?
GRO Biosciences was founded in 2016.
Company Overview
- Headquarters
- Pagliuca Harvard Life Lab 127 Western Ave. Boston, MA 02134 US
- Website
- grobio.com
- NAICS Code
- 3254 - Pharmaceutical and Medicine Manufacturing
- Founded
- 2016
- Employees
- 11-50
Media & News
Funding & Financials
- $60M
GRO Biosciences has raised a total of $60M of funding over 7 rounds. Their latest funding round was raised on Jul 19, 2024 in the amount of $60M.
- $10M
GRO Biosciences's revenue is in the range of $10M
Funding & Financials
- $60M
GRO Biosciences has raised a total of $60M of funding over 7 rounds. Their latest funding round was raised on Jul 19, 2024 in the amount of $60M.
- $10M
GRO Biosciences's revenue is in the range of $10M
Company Leadership
C. J. G.Chief Scientific Officer
E. S.Chief Business Officer- T. L.Chief Development Officer
- E. T.Chief Business Officer Of Ribon Therapeutics
E. T. S.Chief Business Officer
Employee Directory
- E. T.Chief Business Officer Of Ribon Therapeutics
- E. T. S.Chief Business Officer
- R. W.Associate Director Team Lead, Biofoundry
- B. B.Director, Application Sciences
- K. B.Biotechnology Project Manager
Ready to create more pipeline?
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
